PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 1c, Sales Beat Expectations
Tweet Send to a FriendGet Alerts PDLI Hot Sheet
Price: $8.37 +0.24%
Revenue Growth %: -7.0%
Financial Fact:
Net income: 53.47M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -7.0%
Financial Fact:
Net income: 53.47M
Today's EPS Names:
ANF, DXLG, FL, More
Trade PDLI Now!
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q3 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $82.85 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Toro Co. (TTC) Tops Q2 EPS by 13c; Maintains Outlook
- Shoe Carnival, Inc. (SCVL) Tops Q1 EPS by 6c, Guides Q2 In-Line
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
